K. Yang — Union Hospital

Area of research

Oncology · Immunology

Research interest

Research interests include Medicine, Internal medicine, Chemotherapy, Oncology, Lung cancer, and Carboplatin.

Recent publications

Tislelizumab plus chemotherapy versus chemotherapy alone as first-line treatment for advanced squamous non-small-cell lung cancer: final analysis of the randomized, phase III RATIONALE-307 trial

ESMO Open 2024cited by 36position: middledoi

132P Randomized phase III study of tislelizumab plus chemotherapy versus chemotherapy alone as first-line treatment for advanced squamous non-small cell lung cancer (sq-NSCLC): RATIONALE-307 updated analysis

Immuno-Oncology Technology 2022cited by 5position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

— · 2 papers (2022–2024)— · 2 papers (2022–2024)— · 2 papers (2022–2024)— · 2 papers (2022–2024)Yinan Yu · Harbin Medical University1 papers (2022–2022)— · 1 papers (2022–2022)J. Zhao · Ministry of Education1 papers (2022–2022)— · 1 papers (2022–2022)Xiao Lin · Sun Yat-sen University Cancer Center1 papers (2024–2024)J. Zhao · South China Agricultural University1 papers (2024–2024)— · 1 papers (2022–2022)Meili Sun · Shandong University1 papers (2024–2024)Jie Wang · Qiqihar University1 papers (2024–2024)Yong Song · Nanjing University of Chinese Medicine1 papers (2024–2024)Yan Yu · Binzhou Medical University1 papers (2024–2024)— · 1 papers (2022–2022)Wangang Zheng · Sinopec (China)1 papers (2024–2024)Y. Hu · Lawrence Berkeley National Laboratory1 papers (2024–2024)Xiaohua Yu · Guangzhou University of Chinese Medicine1 papers (2024–2024)J. Wang · Chinese Academy of Medical Sciences & Peking Union Medical College1 papers (2022–2022)

Looking for a research collaborator?

Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.

Find collaborators in Oncology · Immunology →